Tampa, Florida-based Acentus, a national medical supplier, specializes in the delivery of continuous glucose monitors (CGMs).
Zoplar has secured $3.4 Mn in a Series A funding round led by Blume Ventures, along with participation from other investors.
The Acentus transaction follows Henry Schein’s acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback